Introduction
Gaucher disease is a genetic disorder caused by the deficiency of an enzyme called glucocerebrosidase which is responsible for breaking down the fatty substance glucocerebroside (also called Gaucher cells). When this enzyme is deficient or absent, Gaucher cells accumulate in organs such as the spleen, liver, and bone marrow. This accumulation causes a range of symptoms and complications, including splenomegaly (enlargement of the spleen) which affects the function of the spleen.
Understanding gaucher disease
Gaucher disease is inherited in an autosomal recessive manner, meaning that a person must inherit two defective copies of the GBA gene(one from each parent) to develop the condition. There are three main types of Gaucher disease, classified based on the presence and severity of neurological symptoms:
- Type 1 (Non-neuronopathic): The most common form, which primarily affects the spleen, liver, and bones but does not involve the brain or nervous system.
- Type 2 (Acute neuronopathic): A rare and severe form that affects the nervous system and leads to early death, usually in infancy or early childhood.
- Type 3 (Chronic neuronopathic): A form that involves both the organs and the nervous system, with symptoms appearing later in childhood or adolescence.
The degree and types of symptoms vary widely even within each subtype of Gaucher disease. Symptoms commonly experienced include abdominal pain(from enlargement of the liver and spleen), clotting disorders and skeletal problems from the accumulation of this fatty substance within organs.
The spleen and its function
The spleen is an organ located in the upper left part of the abdomen. It plays a critical role in the body’s immune system and in the maintenance of healthy blood cells. The spleen’s main functions include:
- Filtering blood: Removing old and damaged red blood cells and recycling iron
- Immune response: Producing white blood cells and antibodies to fight infection
- Blood storage: Storing platelets and red blood cells to release into the bloodstream when needed
Splenomegaly in gaucher disease
One of the hallmark features of Gaucher disease is splenomegaly. The accumulation of Gaucher cells can result in a spleen that is several times larger than its normal size.
Symptoms of splenomegaly
The enlargement of the spleen in Gaucher disease can cause a variety of symptoms, including:
- Abdominal pain and fullness: A significantly enlarged spleen can cause discomfort or pain in the abdomen. It can also lead to a feeling of fullness due to the spleen pressing against the stomach.
- Anaemia: The spleen plays a role in filtering and breaking down red blood cells however when enlarged it can lead to the destruction of red blood cells and cause a low blood cell count leading to fatigue and generalised weakness.
- Thrombocytopaenia: The spleen may trap platelets, leading to a low platelet count and an increased risk of bleeding and bruising.
- Leukopaenia: The spleen alongside the bone marrow can cause destruction of white blood cells, increasing susceptibility to infections.
Complications of splenomegaly
The complications associated with splenomegaly in Gaucher disease can be severe and affect various aspects of health. These include:
- Hypersplenism: This is a condition where the enlarged spleen becomes overactive in removing blood cells, leading to pancytopenia(a reduction in red blood cells, white blood cells, and platelets). Hypersplenism can exacerbate anaemia, increase the risk of infection, and cause excessive bleeding.
- Splenic rupture: A severely enlarged spleen is at risk of rupturing, which is a life-threatening condition. A ruptured spleen can cause severe internal bleeding, leading to shock and requiring emergency medical care and possibly surgery.
- Skeletal abnormalities: Gaucher cells can infiltrate the bone marrow and weaken bones. This can lead to bone pain, fractures, and a condition known as avascular necrosis, where bone tissue dies due to lack of blood supply.
- Impaired growth: Children with Gaucher disease may experience delayed growth and delayed puberty due to the body's focus on managing the disease rather than growing and developing normally.1,2 Splenomegaly will lead to haematological issues and increased metabolic stress on the body which will affect growth.
Diagnosis
Diagnosing Gaucher disease often involves a combination of clinical examination, family history, and specific tests. These tests include:
- Blood tests: To check for anaemia, thrombocytopenia, and other blood abnormalities
- Enzyme analysis: Measuring the level of glucocerebrosidase enzyme in white blood cells or fibroblasts
- Genetic testing: Identifying mutations in the GBA gene to confirm the diagnosis
- Imaging: Ultrasound, CT scans, or MRI to assess the size of the spleen and other affected organs
Treatment options
While there is no cure for Gaucher disease, several treatment options are available to manage symptoms and complications:
- Enzyme Replacement Therapy (ERT): This involves regular intravenous infusions of synthetic glucocerebrosidase to replace the deficient enzyme. ERT can significantly reduce spleen size and improve blood counts.
- Substrate Reduction Therapy (SRT): This oral medication reduces the production of glucocerebroside, thereby decreasing its accumulation in the body.
- Splenectomy: In severe cases, removal of the spleen may be necessary to reduce the burden of symptoms. However, this is usually considered a last resort due to the spleen’s important role within the body
- Supportive Care: Managing symptoms such as pain and fatigue, and addressing complications like anaemia and thrombocytopaenia with blood transfusions and medications.5
Living with gaucher disease
Living with Gaucher disease and managing symptoms associated with splenomegaly involves regular medical care and monitoring. Patients often require a multidisciplinary approach, including specialists in genetics, haematology, and gastroenterology. Additionally, lifestyle adjustments and supportive therapies can help improve quality of life.
- Regular monitoring: Routine blood tests and imaging studies to monitor the disease’s progression and response to treatment.
- Healthy diet: A balanced diet rich in iron and vitamins can help manage anaemia and overall health.
- Physical activity: Engaging in safe physical activities to maintain bone and muscle strength is beneficial, whilst also avoiding high-impact sports that could risk splenic injury and worsening symptoms
- Emotional support: Access to counselling and support groups can help patients and families cope with the emotional and psychological aspects of the disease.
Summary
Gaucher disease is a genetic disorder that significantly impacts the spleen, leading to its enlargement, known as splenomegaly. This condition can cause various symptoms such as abdominal pain, fatigue, and increased susceptibility to infections due to the spleen's role in filtering blood and managing blood cells. The enlargement of the spleen can lead to serious complications, including hypersplenism(overactive spleen), increased risk of splenic rupture, and bone issues due to the infiltration of Gaucher cells.
Early diagnosis and appropriate treatment are vital for managing Gaucher disease and its associated splenomegaly. Treatments like enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) can help reduce spleen size and improve blood cell counts, significantly improving patients' quality of life. In severe cases, splenectomy (surgical removal of the spleen) might be considered, though it is usually a last resort due to the spleen's important haematological and immune function within the body
Living with Gaucher disease requires regular medical monitoring, a healthy lifestyle, and supportive care. A multidisciplinary approach involving specialists in genetics, hematology, and other fields can help manage the disease's various aspects effectively. Additionally, emotional support through counseling and support groups can provide valuable help to patients and their families.
Understanding Gaucher disease and its impact on the spleen empowers patients and healthcare providers to make informed decisions about treatment and management, aiming for a better quality of life despite the challenges posed by the condition.3,4
FAQs
What causes gaucher disease?
Gaucher disease is caused by mutations in the GBA gene, leading to a deficiency of the enzyme glucocerebrosidase. This enzyme deficiency results in the accumulation of glucocerebroside(Gaucher cells) in various organs.
How is splenomegaly diagnosed in gaucher disease?
Splenomegaly is diagnosed through physical examination, blood tests, enzyme analysis, genetic testing, and imaging studies such as ultrasound, CT scans, or MRI.
Can gaucher disease be cured?
There is currently no cure for Gaucher disease, but treatments like enzyme replacement therapy and substrate reduction therapy can manage symptoms and improve quality of life.
What are the risks of an enlarged spleen?
Risks of an enlarged spleen include hypersplenism, splenic rupture, anemia, thrombocytopenia, leukopenia, skeletal abnormalities, and impaired growth in children.
What treatment options are available for splenomegaly in gaucher disease?
Treatment options include enzyme replacement therapy, substrate reduction therapy, splenectomy in severe cases, and supportive care for managing symptoms and complications.
How can individuals with gaucher disease manage their condition?
Managing Gaucher disease involves regular medical care, a healthy diet, safe physical activity, and emotional support. Regular monitoring and a multidisciplinary approach involving different teams are essential.
Is genetic counselling recommended for families affected by gaucher disease?
Yes, genetic counselling is recommended for families affected by Gaucher disease to understand the inheritance pattern, risks for future children and options for genetic testing and family planning.
References
- Linari S, Castaman G. Hematological manifestations and complications of Gaucher disease. Expert Review of Hematology [Internet]. 2016 [cited 2024 Jul 3]; 9(1):51–8. Available from: http://www.tandfonline.com/doi/full/10.1586/17474086.2016.1112732.
- Thomas AS, Mehta A, Hughes DA. Gaucher disease: haematological presentations and complications. Br J Haematol [Internet]. 2014 [cited 2024 Jul 3]; 165(4):427–40. Available from: https://onlinelibrary.wiley.com/doi/10.1111/bjh.12804.
- Nagral A. Gaucher Disease. Journal of Clinical and Experimental Hepatology [Internet]. 2014 [cited 2024 Jul 3]; 4(1):37–50. Available from: https://www.sciencedirect.com/science/article/pii/S0973688314000115.
- Adar T, Ilan Y, Elstein D, Zimran A. Liver involvement in Gaucher disease – Review and clinical approach. Blood Cells, Molecules, and Diseases [Internet]. 2018 [cited 2024 Jul 3]; 68:66–73. Available from: https://www.sciencedirect.com/science/article/pii/S1079979616301218.
- Bennett LL, Mohan D. Gaucher Disease and Its Treatment Options. Ann Pharmacother [Internet]. 2013 [cited 2024 Jul 3]; 47(9):1182–93. Available from: http://journals.sagepub.com/doi/10.1177/1060028013500469.

